These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8781296)

  • 1. Effects of M16209, a new antihyperglycemic agent, on insulin sensitivity in vivo: euglycemic clamp studies in rats.
    Ohta M; Murakami N; Kato K; Mizota M; Miwa I; Okuda J; Yoshimasa Y; Kuzuya H; Nakao K; Imura H
    Metabolism; 1996 Sep; 45(9):1095-100. PubMed ID: 8781296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of insulin resistance in genetically obese rodents by M16209, a new antidiabetic agent.
    Murakami N; Ohta M; Hashimoto K; Kato K; Mizota M; Miwa I; Okuda J; Inoue G; Kuzuya H; Nakao K; Imura H
    Eur J Pharmacol; 1996 May; 304(1-3):129-34. PubMed ID: 8813594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihyperglycemic effects of M16209, a novel aldose reductase inhibitor, in normal and diabetic rats.
    Nakayama K; Murakami N; Ohta M; Kato K; Ida K; Mizota M; Miwa I; Okuda J
    Eur J Pharmacol; 1995 Mar; 276(1-2):77-83. PubMed ID: 7781698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of glycolysis in erythrocytes by the antidiabetic agent M16209.
    Hashimoto K; Murakami N; Ohta M; Kato K; Mizota M; Miwa I; Okuda J
    Biol Pharm Bull; 1996 Jun; 19(6):809-13. PubMed ID: 8799477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihyperglycemic mechanism of M16209, an antidiabetic agent, in 3T3-L1 adipocytes.
    Murakami N; Inoue G; Okamoto M; Yoshimasa Y; Kohno S; Hayashi T; Kato K; Kuzuya H; Nakao K
    Life Sci; 1997; 60(20):1821-31. PubMed ID: 9150422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of M16209 on insulin secretion in isolated, perfused pancreases of normal and diabetic rats.
    Nakayama K; Murakami N; Ohta M; Kato K; Notsu T; Mizota M; Miwa I; Okuda J
    Eur J Pharmacol; 1995 Mar; 276(1-2):85-91. PubMed ID: 7781699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of novel aldose reductase inhibitors, M16209 and M16287, in comparison with known inhibitors, ONO-2235 and sorbinil.
    Kato K; Nakayama K; Mizota M; Miwa I; Okuda J
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1540-5. PubMed ID: 1934175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.
    Kim JK; Wi JK; Youn JH
    Diabetes; 1996 Apr; 45(4):446-53. PubMed ID: 8603766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats.
    James DE; Jenkins AB; Kraegen EW
    Am J Physiol; 1985 May; 248(5 Pt 1):E567-74. PubMed ID: 3887942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of exercise training on in vivo insulin action in individual tissues of the rat.
    James DE; Kraegen EW; Chisholm DJ
    J Clin Invest; 1985 Aug; 76(2):657-66. PubMed ID: 3897288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent.
    Roy D; Perreault M; Marette A
    Am J Physiol; 1998 Apr; 274(4):E692-9. PubMed ID: 9575831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of novel aldose reductase inhibitors, M16209 and M16287, on streptozotocin-induced diabetic neuropathy in rats.
    Kato K; Nakayama K; Ohta M; Murakami N; Murakami K; Mizota M; Miwa I; Okuda J
    Eur J Pharmacol; 1991 Feb; 193(2):185-91. PubMed ID: 1828768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of short-term testosterone exposure on insulin sensitivity of muscles in female rats.
    Holmäng A; Larsson BM; Brzezinska Z; Björntorp P
    Am J Physiol; 1992 Jun; 262(6 Pt 1):E851-5. PubMed ID: 1616020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of insulin action in muscle: influence of blood flow.
    James DE; Burleigh KM; Storlien LH; Bennett SP; Kraegen EW
    Am J Physiol; 1986 Oct; 251(4 Pt 1):E422-30. PubMed ID: 3532818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of insulin-mediated rat muscle glucose uptake and microvascular perfusion by 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside.
    Bradley EA; Zhang L; Genders AJ; Richards SM; Rattigan S; Keske MA
    Cardiovasc Diabetol; 2015 Jul; 14():91. PubMed ID: 26194188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo.
    Clerk LH; Rattigan S; Clark MG
    Diabetes; 2002 Apr; 51(4):1138-45. PubMed ID: 11916937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of nitric oxide synthase inhibitor on improved insulin action by pioglitazone in high-fructose-fed rats.
    Koshinaka K; Oshida Y; Han YQ; Ohsawa I; Sato Y
    Metabolism; 2004 Jan; 53(1):22-7. PubMed ID: 14681837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues.
    Virkamäki A; Daniels MC; Hämäläinen S; Utriainen T; McClain D; Yki-Järvinen H
    Endocrinology; 1997 Jun; 138(6):2501-7. PubMed ID: 9165041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior eccentric contractions impair maximal insulin action on muscle glucose uptake in the conscious rat.
    Asp S; Watkinson A; Oakes ND; Kraegen EW
    J Appl Physiol (1985); 1997 Apr; 82(4):1327-32. PubMed ID: 9104872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of novel hydantoin derivatives with aldose reductase inhibiting activity on galactose-induced cataract in rats.
    Kato K; Nakayama K; Ohta M; Murakami N; Murakami K; Mizota M; Miwa I; Okuda J
    Jpn J Pharmacol; 1990 Dec; 54(4):355-64. PubMed ID: 2128352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.